Niva Bupa Health Insurance Allots 14,76,432 Equity Shares Under ESOP Schemes
Niva Bupa Health Insurance Company Ltd announced the allotment of 14,76,432 equity shares following the exercise of options by eligible grantees under its employee stock option plans. The shares were allotted on June 23, 2026, across two specific schemes: the Niva Bupa Employee Stock Option Plan 2020 and the Niva Bupa Employee Stock Option Plan 2024.The allotment details show a split of the new equity between the two existing ESOP plans. A total of 14,76,432 shares were issued, with face value set at ₹10 each.
Key figures regarding the ESOP allotment are presented below:
| ESOP Scheme | Number of Equity Shares Allotted |
|---|---|
| ESOP Scheme 2020 | 2,42,855 |
| ESOP Scheme 2024 | 12,33,577 |
| Total | 14,76,432 |
The company stated that the newly allotted equity shares will rank pari-passu with all existing equity shares of Niva Bupa Health Insurance Company Ltd.
Following this allotment, the paid up equity share capital of the company has increased significantly. The total paid up equity share capital now stands at ₹18,49,23,37,030, comprising 1,84,92,33,703 Equity Shares, each with a face value of ₹10.
NIVABUPA Stock Price Movement
Shares of Niva Bupa Health Insurance Company Limited settled nearly flat today, closing at ₹86.68 after trading in the insurance sector. The stock finished its session within the intraday range of ₹85.7 and ₹88.31, with a volume of 1,637,723 shares recorded.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.